Analyst firms · Jefferies · HIMS
Jefferies HIMS price target and rating history
Hims & Hers Health Inc. (HIMS) · Health Care
Jefferies rates Hims & Hers Health Inc. (HIMS) Hold with a $15 price target, as of its latest action on Apr 16, 2024. It has published 3 rating actions on HIMS since December 2021, including 1 upgrade and 1 downgrade. Across 5 firms with a HIMS price target in the last 12 months, the median target is $33.
- Current rating
- Hold
- Price target
- $15
- Median target, all firms
- $33
- Actions on HIMS
- 3
Jefferies price target on HIMS
Every Jefferies rating on HIMS
- Apr 16, 2024
- Feb 9, 2023
- Dec 2, 2021
How other firms rate HIMS
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Needham | Buy | $35 | May 12, 2026 |
| Citigroup | Neutral | $24 | Mar 10, 2026 |
| BofA Securities | Neutral | $23 | Mar 10, 2026 |
| BTIG | Neutral | Feb 24, 2026 | |
| Evercore ISI | In-line | $33 | Jan 12, 2026 |
| Barclays | Overweight | $48 | Dec 9, 2025 |
Questions about Jefferies and HIMS
- What is Jefferies's price target for HIMS?
- Jefferies's latest stated price target for Hims & Hers Health Inc. (HIMS) is $15, from its action on Apr 16, 2024.
- What is Jefferies's rating on HIMS?
- Jefferies rates HIMS Hold, a neutral rating, as of Apr 16, 2024.
- When did Jefferies last change its view on HIMS?
- On Apr 16, 2024, Jefferies downgrades to Hold from Buy, price target $17 to $15.
- How does Jefferies's HIMS target compare with other analysts?
- Across 5 firms with a HIMS price target in the last 12 months, the median target is $33.
More HIMS rating histories
All Jefferies ratingsHIMS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.